Ophthalmology

An analysis of a commercial claims database offers insight into the increase in vision-threatening eye disease among people with diabetes aged younger than 65 years from 2009-2018, with results also detailing trends in anti-VEGF therapy during the same period.

The research suggests additional glaucoma surgery was required more frequently after trabeculectomy than after Baerveldt glaucoma implant surgery.

Circumpapillary structure measurements showed a dose-dependent increase with the induction of negative pressure.

Eyes with concurrent uveitis in a Swedish cohort had worse BCVA prior to and following cataract surgery, although visual improvement was greater compared to control eyes.

Based on 2021 data from NHATS, vision impairment is more prevalent among those who are older, Hispanic, non-White, less educated, and lower income.

Higher preoperative visual acuity in patients with dTRD was associated with higher vision after PPV, suggesting the importance of early intervention.

Five years of treatment follow-up in the Fight Retinal Blindness registry provided evidence that SRF protected against the development of subfoveal and extrafoveal macular atrophy.

Both rates of macular vessel density loss and ganglion cell complex thinning are associated with central visual field loss in eyes with early glaucoma.

A post-hoc analysis suggests that increased dietary nitrate intake was associated with a decreased risk of late AMD, but this association was attenuated after the addition of plant-based dietary patterns.

A group of investigators, researchers and policymakers discuss the issues, innovations and aspirations that may define 2023 advances.

From a topical gene therapy to a debated heart failure option, a litany of unique agents are anticipated for FDA decision in the new year.

A new Q&A focuses on hybrid telehealth in ophthalmology and subspecialty-level care, and its potential to create new opportunities and increase access for patients.

A moderate negative correlation was observed between changes in BCVA and changes in CST at weeks 12 and 24.

Patients with DR who received intravitreal anti-VEGF injections had a risk of cardiovascular events similar to those who received laser or steroid treatment

A retrospective cohort analysis of patients in Finland show a notable overlap of the 2 forms of vision loss.

An analysis of the change from preoperative to final BCVA showed no difference between the deferred and immediate surgery subgroups.

SB11 and ranibizumab appeared to have comparable immunogenicity and safety profiles in a post-hoc analysis of a phase 3 equivalence trial.

People with diabetes were 11% more likely to develop glaucoma and/or OHT, and individuals with glaucoma and/or OHT were 12% more likely to develop diabetic retinopathy.

After decades of unmet needs in the progressive form of vision loss, the complement inhibitor drug class is nearing the market for affected patients.

New research suggests lower central foveal thickness fluctuation scores with patients on ranibizumab were associated with the greatest gains in vision.

Dr. Glasser shares perspective on the adoption of telehealth in ophthalmology and the importance of increased funding to provide sufficient reimbursement for all physician services.

Individuals living in lower-income situations were also more likely to have vision impairment, use eye care services less, and have lower adherence to eye examinations.

Macular holes in stage 2 progress faster than those in stages 3 and 4, making it beneficial to perform vitrectomy without delay in this population.

The results from the artificial intelligence deep learning model indicated alterations in the SD-OCT imaging regions attributed to the retinal nerve fiber and choroid layers.

Adults with vision impairment had a lower prevalence of having health insurance coverage and a usual health care provider, and a higher prevalence of having an unmet health care due to cost.

A clinical trial from Norway showed inconclusive results, and challenges in the study design.

Visual complaints during atropine therapy may be reduced by using progressive addition lenses.

A recent quality improvement study demonstrated the potential to enhance ophthalmic telehealth using asynchronous testing, which was effective in subspecialty-level care.

The study reported 6.1% of study patients with NTG had ODD diagnosed using EDI-OCT, compared to the 1.8% – 2.0% reported in the general population.

The implant significantly reduced CRT in patients with RVO-ME, but the study reported no relationship between OCT biomarkers and clinical outcomes.